At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,228 enrolled
Drug / intervention
acetylsalicylic-acid (aspirin) +1 moredrug
Likely dose
acetylsalicylic-acid (aspirin) 81mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effects of Aspirin in Gestation and Reproduction: A Multi-center, Controlled, Double-blind Randomized Trial.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)·interventional·Posted Apr 30, 2007·Updated Feb 3, 2017
In Brief
A clinical study evaluating acetylsalicylic-acid (aspirin) and Folic acid for Birth and Spontaneous Abortion. Completed, enrolled 1,228 participants across 4 sites.
Detailed Summary
The primary objective of the study is to help elucidate the effects of low-dose aspirin in combination with folic acid on the incidence of live births and spontaneous abortions among a group of women who become pregnant compared to a control group.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBirth, Spontaneous Abortion
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 2007
Enrollment StartJun 2007
Primary CompletionJul 2012
TodayJul 2026
First PostedApr 30, 2007
Enrollment StartJun 1, 2007
Primary CompletionJul 1, 2012
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 19.2 years ago
Interventions
acetylsalicylic-acid (aspirin)drug
81mg of low-dose aspirin plus 400micrograms of folic acid.
Folic aciddietary
400micrograms of folic acid.